Financial Calendar
POXEL (Euronext - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and NASH, announces its schedule for the publication of financial information for 2019.
| Event | Date* |
|---|---|
| 2018 Fourth Quarter Financial Update | February 12, 2019 |
| 2018 Full Year Statement | March 21, 2019 |
| 2019 First Quarter Financial Update | April 8, 2019 |
| 2019 Second Quarter Financial Update | July 15, 2019 |
| 2019 First Half Statement | August 26, 2019 |
| 2019 Third Quarter Financial Update | October 7, 2019 |
| 2019 Fourth Quarter Financial Update | February 12, 2020 |
*Subject to modification.